The number of antigen-specific IFN-γ producing T cells was significantly increased in tumour-bearing mice treated with OxPt/DHA, indicating that OxPt/DHA effectively generates tumour-specific T cell response, which could be further enhanced by the addition of α-PD-L1. The gene discussed is IFNG; the disease is neoplasm.